Cardiac Biomarker
Cardiac biomarker detection based on nanostructured biosensors
... and cardiac strokes were estimated to be ...of cardiac arrest, as these are not point-of-care techniques and require expert technician as well as high-end laboratory ...of cardiac ailments. Among ...
6
Electrochemiluminescence platform for the detection of C-reactive proteins : application of recombinant antibody technology to cardiac biomarker detection
... the cardiac biomarker C-Reactive protein at the fg level, which to our knowledge is the first reported sensor capable of detecting CRP at these detection ...
5
Perspective of st2 as a cardiac biomarker
... for cardiac remodeling and fibrosis. The release of cardiac biomarkers natriuretic peptides [NPs] neutralize the myocardial stretch and reduce the volume overload but do not regress the process of ...
6
CARDIAC BIOMARKER PROFILING IN EVALUATION OF RISK IN ACUTE CORONARY SYNDROME
... This study focused on newer generation biomarkers in patients suffering acute coronary syndrome and their incremental value for risk stratification. So, the aim of this study is to evaluate the most important ...
7
DIFFERENTIAL EXPRESSION OF CARDIAC BIOMARKER BASED ON GENDER, AGE, DIABETIC, BLOOD PRESSURE, SMOKING AND DRINKING IN PATIENTS OF MYOCARDIAL INFARCTION
... ideal cardiac marker are: i) High sensitivity- Abundant in cardiac tissue, ii) High specificity - Absent from non-myocardial tissue; Not detectable in blood from non- diseased subjects, iii) Release - Rapid ...
6
Fabrication of Electrochemical Immunosensor for Cardiac Biomarker Troponin I Determination and Its Potential for Acute Myocardial Infarction Diagnosis
... constant potential of -0.2V and varying pH values. As can be seen from (Fig. 4A), the current peak showed a gradual increase firstly and then a gradual decrease with increasing pH value. The maximum current peak was ...
11
Electrochemical Detection of Cardiac Biomarker Troponin I at Gold Nanoparticle-Modified ITO Electrode by Using Open Circuit Potential
... Gold nanoparticles (GNPs) have been electrodeposited on indium tin oxide (ITO) and applied to detect molecular interaction between antigen and antibody by measuring open circuit potential (OCP). As a capture protein for ...
11
PREDICTORS OF DEPRESSED LEFT VENTRICULAR FUNCTION IN PATIENTS PRESENTING WITH ST-ELEVATION MYOCARDIAL INFARCTION
... best cardiac biomarker to predict infarct size, left ventricular ejection fraction (LVEF), and clinical outcome in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment ...
18
Troponin release following endurance exercise: is inflammation the cause? a cardiovascular magnetic resonance study
... induced cardiac biomarker release is not associated with changes in biventricular systolic function or indeed any detectable myocardial damage (inflammation, oedema, hyperemia, or fibrosis) using current ...
7
FET-biosensor for cardiac troponin biomarker
... of cardiac biomarker levels in patients; thus, allowing doctors to justify their decision making in the diagnostics of AMI with accurately, quickly, and ...
5
Urine klotho is a potential early biomarker for acute kidney injury and associated with poor renal outcome after cardiac surgery
... AKI following cardiac surgery is a world health issue. Serum creatinine and urine output remains the gold standard for clinical diagnosis of AKI, although both were believed as unspecific markers for kidney ...
8
Combined ECG, Echocardiographic, and Biomarker Criteria for Diagnosing Acute Myocardial Infarction in Out of Hospital Cardiac Arrest Patients
... 12. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Böttiger BW, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiolo- gy, treatment, and prognostication. A consensus statement from the International ...
8
Correcting for the influence of sampling conditions on biomarkers of exposure to phenols and phthalates: a 2-step standardization method based on regression residuals
... Each pregnant woman provided only a single urine sample, which probably limited the accuracy of our estimates of the influence of sampling conditions. In practice, many studies in the general population rely on a single ...
14
Original Article Expression of CHD5 may serve as an independent biomarker of prognosis in colorectal cancer via immunohistochemical staining
... Abstract: Chromodomain helicase DNA binding protein 5 (CHD5) acts as a tumor suppressor in various types of cancer and belongs to CHD protein family. However, no prognostic role for CHD5 has yet been indicated in ...
7
ISOLATION AND DEVELOPMENT OF AN HPLC METHOD FOR THE QUANTIFICATION OF A BIOMARKER IN THE ROOTS OF PAULLINIA PINNATA
... The biomarker was isolated from the chloroform fraction (7.0g), which has been determined to be the active fraction 10 , by column chromatography using silica gel (70–230 mesh from BDH). Gradient elution was ...
7
cMRI-BED: A novel informatics framework for cardiac MRI biomarker extraction and discovery applied to pediatric cardiomyopathy classification
... We present below a BRL decision tree [31] model to illustrate the kinds of interactions between cMRI-derived markers that can be used for automatic classification. We used a supervised discretization algorithm called ...
16
A simulation study on estimating biomarker–treatment interaction effects in randomized trials with prognostic variables
... a biomarker–treatment interaction can be considered as a requirement for such treatment individualization [2], and consequently an interaction between the biomarker of interest and treatment has to be ...
14
Linking hypothetical knowledge patterns to disease molecular signatures for biomarker discovery in Alzheimer’s disease
... There is an unmet need for strategies to model and find potential biomarkers for the identification of early disease- initiating events/mechanisms. In particular, in complex dis- eases like AD, rather than sticking to ...
11
Original Article Serum proteomics study reveals candidate biomarkers for systemic lupus erythematosus
... the biomarker discovery stage, and five dif- ferent sample cohorts (SLE active, SLE inac- tive, RA, SS and healthy control) were used for the validation ...
18
Wang_unc_0153D_19353.pdf
... a biomarker-guided (strategy) design has low efficiency and has not been commonly used in practice because many patients receive the same treatment in both guided and un-guided arms, diluting the treatment ...
136